Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Rhea-AI Summary
Serina Therapeutics (NYSE American: SER), a clinical-stage biotech company, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. Steve Ledger, Serina's Interim CEO, will present on September 11, 2024, at 12:00 p.m. ET.
Serina is known for developing its proprietary POZ Platform™ drug delivery technology. Investors and interested parties can access a live webcast of the presentation through the Investor section of Serina's website. An archived replay will also be available for a time after the event.
This presentation offers an opportunity for Serina to showcase its innovative technology and progress to a global investment audience, potentially impacting its stock performance and investor interest.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, SER gained 0.28%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
HUNTSVILLE, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced that Steve Ledger, Interim Chief Executive Officer of Serina, will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024, at 12:00 p.m. ET.
A live webcast of the presentation can be accessed from the Investor section of Serina’s website, where an archived replay of the event will also be available for a limited time.
About Serina Therapeutics
Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform™ provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology. For more information, please visit https://serinatherapeutics.com.
For inquiries, please contact:
Investor.relations@serinatherapeutics.com
(256) 327-9630
FAQ
When is Serina Therapeutics (SER) presenting at the H.C. Wainwright Global Investment Conference?
Who will be presenting for Serina Therapeutics (SER) at the investment conference?
How can investors access Serina Therapeutics' (SER) presentation at the conference?
What is Serina Therapeutics' (SER) main focus in drug development?
What is Serina Therapeutics' (SER) stock symbol and exchange?
